Displaying drugs 14876 - 14900 of 14970 in total
CRA_1801
Experimental
Bis(5-Amidino-2-Benzimidazolyl)Methanone
Experimental
4-Iodobenzo[B]Thiophene-2-Carboxamidine
Experimental
ZK-806711
Experimental
Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone
Experimental
XL019
XL019 is a selective inhibitor of the cytoplasmic tyrosine kinase JAK2. An IND for XL019 was filed by Exelixis in May 2007.
Investigational
5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone
Experimental
Metizoline
Experimental
Gantacurium
Gantacurium chloride is a new, investigational, non-depolarizing ultra-short acting neuromuscular blocker. It is being developed by Avera Pharmaceuticals.
Investigational
Carphenazine
Carphenazine is an antipsychotic drug, used in hospitalized patients in the management of chronic schizophrenic psychoses.
Withdrawn
Atpenin A5
Experimental
105AD7
105AD7 is a human monoclonal antibody that mimics the complement regulatory protein, CD55, overexpressed by many solid tumours including osteosarcoma. 105AD7 induced antitumour inflammatory responses in metastatic colorectal cancer patients. 105AD7 may be a suitable vaccine for treatment of this disease.
Investigational
Acetylcysteine zidrimer
Investigational
ZK-805623
Experimental
ALS-08
ALS-08 is a proprietary creatine-derivative that is being developed as a potential therapeutic for amyotrophic lateral sclerosis (ALS). It is being developed by Avicena Group, Inc.
Investigational
Displaying drugs 14876 - 14900 of 14970 in total